Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy
OPEN Clinical kidney journal | 7 Aug 2019
MJ Pérez-Sáez, B Yu, A Uffing, N Murakami, TJ Borges, J Azzi, S El Haji, S Gabardi and LV Riella
Conversion from tacrolimus to belatacept has been shown to be beneficial for an increasing number of kidney transplant (KT) patients. Predicting factors for favorable outcomes are still unknown. We aimed to investigate whether histological vascular lesions at the time of conversion might correlate with greater improvement in renal function post-conversion.
* Data courtesy of Altmetric.com